Search - tctmd.com

Displaying 561 - 580 of 955

Sort: Relevancy | Date

News Daily News

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Yael L. Maxwell

July 22, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

News Daily News

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

Michael O'Riordan

June 23, 2016

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

Presentation TVT 2016

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Presenter: Marco Barbanti

June 17, 2016

Presentation TVT 2016

Severe LVOT Calcification and TAVR: Assessment and Procedural Decision Making

Presenter: Hasan Jilaihawi

June 17, 2016

Presentation TVT 2016

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Clinical Decisions in Patients With Low-Gradient AS

Presenter: Allan Schwartz

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Yael L. Maxwell

June 15, 2016

News Daily News

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Michael O'Riordan

June 07, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Daily News

La Evolución de la TAVR en Dinamarca podría Tener Imlpicacines en Otros Países

L.A. McKeown

June 06, 2016

Advertisement

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

La Estenosis Aórtica Persistente de Bajo Flujo Post-TAVR se asocia a una Mortalidad Más Alta al cabo de 1 Año

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Severe LVOT Calcification and TAVR: Assessment and Procedural Decision Making

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Clinical Decisions in Patients With Low-Gradient AS

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

La Evolución de la TAVR en Dinamarca podría Tener Imlpicacines en Otros Países

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content